首页> 美国卫生研究院文献>Oncology Letters >Synthesis biological evaluation and mechanism studies of matrine derivatives as anticancer agents
【2h】

Synthesis biological evaluation and mechanism studies of matrine derivatives as anticancer agents

机译:苦参碱衍生物作为抗癌药的合成生物学评价及机理研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A total of five matrine derivatives were synthesized and evaluated for their anti-proliferation activity using a panel of four human cancer cell lines, including A549 lung, BT20 breast, MCF-7 breast and U2OS osteosarcoma cells. The YF3-5, YF3-7 and YF3-9, three novel compounds, demonstrated increased anti-proliferation activity compared with matrine, of which YF3-5 revealed the strongest anti-proliferation activity with a half-maximal inhibitory concentration value of 15.49–16.67 µM against the four human cancer cell lines. The anti-proliferation mechanism underlying YF3-5 was investigated in the A549 human lung cancer cell line and the results demonstrated that YF3-5 exerted its anti-proliferation activity through the induction of apoptosis and oxidative stress, in addition to arresting the cell cycle at the G1 phase in a dose-dependent manner.
机译:总共合成了五种苦参碱衍生物,并使用一组四个人类癌细胞系(包括A549肺,BT20乳腺,MCF-7乳腺和U2OS骨肉瘤细胞)评估了它们的抗增殖活性。与苦参碱相比,三种新型化合物YF3-5,YF3-7和YF3-9具有增强的抗增殖活性,其中YF3-5表现出最强的抗增殖活性,半数抑制浓度为15.49–针对四种人类癌细胞系的16.67 µM。在A549人肺癌细胞系中研究了YF3-5的抗增殖机制,结果表明YF3-5通过诱导细胞凋亡和氧化应激发挥其抗增殖活性,此外还抑制了细胞周期。 G1期呈剂量依赖性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号